AMRN's Vascepa Woes, AKRO Awaits Big Day, JNJ's COVID-19 Vaccine Study In Sep

Today's Daily Dose brings you news about Akero's big day; Immunovant's Thyroid Eye Disease trial results; Court ruling in Amarin's patent suit related to Vascepa, Savara's update on its ongoing clinical trials in light of the coronavirus crisis; Johnson & Johnson's progress in its COVID-19 vaccine program.